AgenciesJB Chemicals and Pharmaceuticals on Thursday reported a 12 per cent decline in its consolidated net profit to Rs 105 crore for the first quarter ended June 30. The drug firm had reported a net profit of Rs 119 crore in the April-June quarter of the previous fiscal.
Its revenue from operations rose to Rs 785 crore for the first quarter compared to Rs 606 crore in the year-ago period, the company said in a regulatory filing.
Its revenue from operations rose to Rs 785 crore for the first quarter compared to Rs 606 crore in the year-ago period, the company said in a regulatory filing.
Experience Your Economic Times Newspaper, The Digital Way!
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by